Free: 15-question metabolic assessment — reviewed by the HealthCalculus medical panel. Start now

Insulin Resistance · 14 cited studies

Research on Insulin Resistance

Mechanisms and reversal of insulin resistance — Petersen & Shulman, Newcastle/DiRECT trials, fructose restriction, and CGM evidence.

14

Papers

9

Strong evidence

04–24

Years covered

01The state of the evidence

Where this literature sits

Insulin resistance is the central node of metabolic syndrome — the upstream lesion behind prediabetes, type-2 diabetes, fatty liver, PCOS, and a major component of cardiovascular risk. Petersen & Shulman's mechanism reviews (Physiological Reviews 2018, JCI 2016) trace it to ectopic lipid accumulation in liver and skeletal muscle disrupting insulin-receptor signalling via diacylglycerol-PKCε. The Newcastle/DiRECT trial line of work (Taylor, Lim, Lean) demonstrates the lesion is reversible: an 8-week very-low-calorie diet normalised fasting glucose and beta-cell function, and the 5-year DiRECT extension showed durable T2D remission when weight loss is maintained.

Tools like HOMA-IR (Wallace 2004) provide screening; CGM data (Hall 2018) shows that even 'normoglycemic' adults frequently spike post-meal. Below: the mechanism and reversal literature.

Evidence mix on this topic

  • Strong evidence9
  • Moderate evidence5
Years covered2004–2024
Journals13
Paywalled summaries0
02The studies

Every paper behind the claim

Filter by grade or flip the order. Each card links straight to PubMed, the DOI or the journal — read the original rather than our summary of it.

  • Strong evidence2024

    Beta-cell function and remission of type 2 diabetes (5-year DiRECT extension)

    Taylor R et al. · The Lancet Diabetes & Endocrinology

    5-year DiRECT extension: T2D remission durable when weight loss maintained; relapse predicts beta-cell decline.

    Insulin ResistanceSource ↗
  • Strong evidence2021

    Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2)

    Davies M et al. · The Lancet

    STEP 2: 9.6% body-weight reduction with semaglutide 2.4 mg in T2D over 68 weeks vs 3.4% placebo.

    GLP-1 DrugsInsulin ResistanceSource ↗
  • Strong evidence2018

    Mechanisms of Insulin Action and Insulin Resistance

    Petersen MC, Shulman GI · Physiological Reviews

    Comprehensive review of intramyocellular and hepatic lipid as primary drivers of insulin resistance.

    Insulin ResistanceSource ↗
  • Strong evidence2018

    Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial

    Lean MEJ et al. · The Lancet

    DiRECT trial: 46% achieved T2D remission at 12 months via structured low-calorie weight-loss program.

    Insulin ResistanceSource ↗
  • Moderate evidence2018

    Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss

    Sutton EF et al. · Cell Metabolism

    Early 6h eating window improved insulin sensitivity, BP, and oxidative stress in prediabetic men with no weight change.

    FastingInsulin ResistanceSource ↗
  • Strong evidence2018

    Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome

    Teede HJ et al. · Human Reproduction

    International evidence-based PCOS guideline: lifestyle (diet + exercise) is first-line; metformin and inositol have additional benefit.

    Women-SpecificInsulin ResistanceSource ↗
  • Strong evidence2016

    The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux

    Samuel VT, Shulman GI · Journal of Clinical Investigation

    Comprehensive mechanism review: ectopic lipid in liver and muscle drives insulin resistance via DAG-PKCε.

    Insulin ResistanceSource ↗
  • Moderate evidence2016

    Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome

    Lustig RH et al. · Obesity

    Isocaloric fructose restriction in obese children improved fasting glucose, lipid panel, and DNL within 9 days.

    Insulin ResistanceSource ↗
  • Moderate evidence2013

    Resistance training for diabetes prevention and therapy: experimental findings and molecular mechanisms

    Strasser B, Pesta D · BioMed Research International

    Resistance training improves insulin sensitivity ~30% via increased muscle mass and GLUT4 translocation.

    Exercise & StrengthInsulin ResistanceSource ↗
  • Strong evidence2012

    Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption

    Buxton OM et al. · Science Translational Medicine

    3 weeks of sleep restriction + circadian disruption produced prediabetic-grade insulin resistance and lower metabolic rate.

    Sleep & CircadianInsulin ResistanceSource ↗
  • Strong evidence2011

    Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol

    Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R · Diabetologia

    Newcastle study: very-low-calorie diet normalised fasting glucose and beta-cell function within 8 weeks.

    Insulin ResistanceSource ↗
  • Moderate evidence2007

    Metabolic endotoxemia initiates obesity and insulin resistance

    Cani PD et al. · Diabetes

    High-fat diet raised circulating LPS (endotoxemia), which drove insulin resistance and inflammation in mice.

    Gut MicrobiomeInsulin ResistanceSource ↗
  • Moderate evidence2005

    Role of stress in the pathogenesis of the metabolic syndrome

    Rosmond R · Psychoneuroendocrinology

    Reviews HPA-axis dysregulation as a unifying driver of insulin resistance, visceral adiposity, dyslipidaemia.

    Cortisol & StressInsulin ResistanceSource ↗
  • Strong evidence2004

    Use and abuse of HOMA modeling

    Wallace TM, Levy JC, Matthews DR · Diabetes Care

    Practical guide to HOMA-IR/HOMA-β interpretation — the calculator screening foundation.

    Insulin ResistanceSource ↗
04Straight answers

Insulin Resistance

Reading this evidence honestly

Of the 14 papers filed under this topic, 9 carry a strong-evidence grade — replicated trials or large meta-analyses — and 0 sit in the contested or mechanism-only tiers where the human outcome has not been settled.

A mixed distribution is normal and honest. Topics where every paper is graded strong are usually topics where the inconvenient papers have been quietly left out.

Strong evidence64%

9 of 14 papers

Moderate evidence36%

5 of 14 papers

Evidence grades describe the strength of the research, not a promise about your outcome.

Papers describe populations. Your labs describe you.

The free assessment takes the research above and asks which parts of it apply to your pattern — then names the protocol the evidence actually supports for it.

Every claim citedOpen the paper, check us.
Graded honestlyContested is labelled contested.
No guaranteed numbersIndividual results vary.

Educational only, not medical advice. Citing a study is not a recommendation to act on it. Consult your physician before major dietary changes or altering prescribed medication. These statements have not been evaluated by the Food and Drug Administration. Individual results vary; no outcome is guaranteed.